Patient groups play an important role in vaccine rollout

Canada should immediately adopt a national approach that prioritizes patients with rare diseases in the COVID-19 vaccine rollout.

Immunodeficient patients are more vulnerable, even in non-pandemic times, and it’s a no-brainer to prioritize them for vaccines, writes Pierre Cyr, pulling from his experience with a rare neuromuscular disorder and working in federal and provincial public health policy. Pexels photograph by Gustavo Fring

Opinion

BY PIERRE CYR

May 12, 2021

Along with many Canadians, I’ve been closely watching the provincial approaches to COVID-19 vaccine rollouts. This is both out of self-interest, as someone who wants to be vaccinated, as well as from a longstanding interest in all matters of public health policy. Wh...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy